In a landmark clinical trial, a brain-computer interface has enabled patients with paralysis to walk again, marking a significant advancement in neurotechnology. The study, conducted at a major hospital, involved implanting a device that decodes neural signals and bypasses damaged spinal cords to stimulate leg muscles. Researchers reported that all participants achieved independent ambulation with minimal assistance after six months of training.

The technology, developed by a Swiss-American consortium, uses artificial intelligence to interpret motor intentions from brain activity. Experts caution that widespread application remains years away, citing cost and surgical risks. However, the trial provides proof of concept for restoring mobility in spinal cord injuries, a condition affecting millions globally.

The findings have been published in a peer-reviewed journal.